Key result
A newly developed real-time RT-PCR kit successfully detected HAV genotype IIIA, which had evaded commercially available HAV RNA detection systems in a German blood donation.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
The identification of HAV genotype IIIA in Germany highlights the need for continuous adaptation of diagnostic nucleic acid assays to ensure blood product safety.
BACKGROUND: A blood donation, obtained in 2003 in Germany during the preseroconversion diagnostic window period of a hepatitis A virus (HAV) infection, tested HAV-negative by commercially available HAV reverse transcription-polymerase chain reaction (RT-PCR) detection assays. STUDY DESIGN AND METHODS: The virus responsible for this infection was identified as HAV genotype IIIA by characterization of the nearly complete genome sequence. RESULTS: Thereby, this HAV variant, which was named strain HMH, was detected in Germany for the first time. Because the commercially available HAV RNA detection systems failed to detect this genotype, a real-time RT-PCR kit was developed that allows quantification and detection of all HAV genotypes. The first nearly full-length nucleotide sequence so far available for HAV genotype IIIA is also provided. CONCLUSION: This case demonstrates that owing to the genetic variability of HAV, constant monitoring and adaptation of the diagnostic nucleic acid assays are required to guarantee the safety of blood and blood products.
No takes yet. Share an insight, caveat, or question.
Heitmann et al. (2005) conducted a case report in Hepatitis A virus (HAV) infection (n=1). Newly developed real-time RT-PCR kit vs. Commercially available HAV RT-PCR detection assays was evaluated on Detection of HAV genotype IIIA. A newly developed real-time RT-PCR kit successfully detected HAV genotype IIIA, which had evaded commercially available HAV RNA detection systems in a German blood donation.
Synapse has enriched 10 related papers. Consider them for comparative context: